Stamford, CT -- (SBWIRE) -- 01/13/2014 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Medbox Inc(OTCMKTS:MDBX), Ctrip.com International, Ltd. (ADR)(NASDAQ:CTRP), Conatus Pharmaceuticals Inc(NASDAQ:CNAT), Alpha Natural Resources, Inc.(NYSE:ANR)
Medbox Inc(OTCMKTS:MDBX) opened the session at $42.75, remained amid the day range of $33.25 - $42.95, and closed the session at $34.01. The stock showed a negative performance of -21.36% in previous trading session. The stock gained a volume of 480,304.00 shares and the average volume of the stock remained 194,421.00 shares. Medbox, Inc. develops, sells, and services automated, biometrically controlled dispensing and storage systems for medicine and merchandise applications.
Will MDBX Get Buyers Even After The Recent Rally? Find Out Here
Ctrip.com International, Ltd. (ADR)(NASDAQ:CTRP) traded with volume of 14.38 million shares in the prior session and the average volume of the stock remained 3.89 million shares. The 52 week range of the stock remained $18.87 - $61.09. The stock showed a negative movement of -3.80% and closed its session at $38.95. The market capitalization of the stock remained 5.05 billion. Ctrip.com International, Ltd. (Ctrip) is a travel service provider for hotel accommodations, airline tickets and packaged tours in China.
Why Should Investors Buy CTRP After the Recent Fall? Just Go Here and Find Out
Conatus Pharmaceuticals Inc(NASDAQ:CNAT) exchanged 8.79 million shares and the average volume remained 511,421.00 shares. The stock escalated +45.41% and closed the session at $14.25. The EPS of the stock remained -4.92. The shares outstanding of the stock remained 15.62 million. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States.
For How Long CNAT will fight for Profitability? Read This Trend Analysis report
Alpha Natural Resources, Inc.(NYSE:ANR) gained volume of 10.73 million shares, while the average volume remained 12.03 million shares. The stock decreased -0.96% and finished the session Friday at $6.21. The EPS of the stock remained -4.00. The one month of the stock was -3.57% and three month trend remained positive 5.79%. Alpha Natural Resources, Inc., together with its subsidiaries, engages in extracting, processing, and marketing steam and metallurgical coal in Virginia, West Virginia, Kentucky, Pennsylvania, and Wyoming.
Has ANR Found The Bottom and Ready To Move Up? Find Out Here
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)